Bionpharma recalls

Bionpharma has 4 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 9 Sep 2026. 2 are still ongoing. 2 were reported in the last 12 months.

Total recalls4since 2019
Last 12 months2reported
Class I125% of total
Ongoing2latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 25%Class II 2 50%Class III 1 25%

Why bionpharma is recalled

Product types

By year

Ongoing bionpharma recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIDoxylamine Succinate and Pyridoxine HCl Delayed-Release recalledDoxylamine Succinate And Pyridoxine HydrochlorideBionpharmaOtherNationwide
DrugCLASS IIDivalproex Sodium Delayed-Release Tablets, USP, 500 mg recalledDivalproex SodiumBionpharmaOtherNationwide

All bionpharma recalls, newest first

4 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIDoxylamine Succinate and Pyridoxine HCl Delayed-Release recalledDoxylamine Succinate And Pyridoxine HydrochlorideBionpharmaOtherNationwide
DrugCLASS IIDivalproex Sodium Delayed-Release Tablets, USP, 500 mg recalledDivalproex SodiumBionpharmaOtherNationwide
DrugCLASS IAtovaquone Oral Suspension, USP 750 mg recalled by BionpharmaAtovaquoneBionpharmaSterilityNationwide
DrugCLASS IIClobazam Oral Suspension, 5 mg/mL recalled by BionpharmaClobazamBionpharmaSterilityNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.